HY26 · Released 25 February 2026
EBOS HY26: NPAT up 13% but operating cash flow collapsed 76%
A favourable tax rate flattered bottom-line growth while working capital consumed most of the period's earnings in cash terms.
Read briefing
EBO · NZX
EBOS Group
Healthcare DistributionCovered: HY261 published briefing
EBOS Group is an NZX-listed healthcare distribution company covered by Annolyse across HY26. This page brings together the latest briefing, the current metrics snapshot, and the published history to date in one place.
Table of Contents
Snapshot
Latest metrics
HY26, released 25 February 2026
| Metric | Value |
|---|---|
| Revenue | $6767.7m |
| EBITDA | $302.7m |
| NPAT | $124.8m |
| Operating cash flow | $46.6m |
| OCF / EBITDA % | 15.4% |
| Net debt | $1120.9m |
| Net debt / EBITDA | 3.71x |
| ROE % | 9.2% |
| DPS | 0.6c |
| Payout ratio vs NPAT % | 93.3% |
Longitudinal view
Performance over time
Current-period values from each published briefing, with the most recent reporting period shown first.
← Swipe to view more
| Metric | HY266 MONTHS25 February 2026 |
|---|---|
| Revenue | $6767.7m |
| Revenue growth % | 13.0% |
| EBITDA | $302.7m |
| EBITDA margin % | 4.5% |
| PBT | $162.7m |
| PBT growth % | 4.4% |
| NPAT | $124.8m |
| NPAT growth % | 13.0% |
| Operating cash flow | $46.6m |
| OCF / EBITDA % | 15.4% |
| FCF pre-lease | -$16.1m |
| DPS | 0.6c |
| Payout ratio vs NPAT % | 93.3% |
| ROE % | 9.2% |
| Net debt | $1120.9m |
| Net debt / EBITDA | 3.71x |
| Debtor days | 45 |
| Inventory days | 36 |
| Total assets | $7588.1m |
Source: annolyse.ai/companies/ebo
Accountability
What changed versus the prior briefing
Read the prior briefing's expectations and unresolved questions alongside the subsequent result, without forcing long-form editorial text into narrow cards.
Expectations tracker
Once a second briefing exists for this company, this section will compare the previous briefing's expectations and unresolved issues with what actually happened in the next result.
Archive
Briefing archive
Every published Annolyse briefing for this company appears here in reverse chronological order.
Subscribe
Want the next EBOS Group briefing delivered to your inbox?
Subscribe to get future Annolyse briefings as soon as they are published.